Abstract
BACKGROUND: Oxygen titration is recommended to avoid hyperoxemia and hypoxemia. Automated titration, as well as the target, may have an impact on oxygen utilization, with potential logistical effects in emergency and military transportation. We sought to assess the oxygen flow required for different targets in spontaneously breathing subjects, and to evaluate individualized automated oxygen titration to maintain stable oxygenation in subjects with COPD and healthy subjects with induced hypoxemia.
METHODS: In the first part of the study, oxygen flow was evaluated in hospitalized subjects for different targets from 90% to 98%. Oxygen requirements to reach these targets were determined using a device that automatically adjusts oxygen flow every second on the basis of the target. In the second part of the study, the same automated oxygen titration method was used to correct hypoxemia in subjects with COPD and in healthy subjects with induced hypoxemia while the subjects wore a gas mask. Oxygen flow, , and heart rate were continuously recorded.
RESULTS: Thirty-six spontaneously breathing hospitalized subjects were included in the first part of the study. Oxygen flow was reduced more than 6-fold when the target was decreased from 98% to 90%. The second part of the study included 15 healthy and 9 subjects with stable COPD. In healthy subjects, heterogeneous oxygen flows were required to correct induced hypoxemia (0.2–2.5 L/min). In subjects with COPD, oxygen flow varied from 0 L/min (in 9 of 18 tested conditions) to 2.9 L/min.
CONCLUSIONS: Significant reductions in the amount of oxygen delivered could be obtained with optimized targets. Oxygen delivery through a gas mask to correct hypoxemia is feasible, and automated oxygen titration may help individualize oxygen administration and reduce oxygen utilization. (ClinicalTrials.gov registration: NCT02782936, NCT02809807.)
- gas exchange
- hypoxemia
- gas mask
- protective respiratory devices
- chemical
- biological
- radiological
- nuclear and explosives
- automated oxygen titration
- FreeO2
Footnotes
- Correspondence: François Lellouche MD PhD, Centre de Recherche de l’Institut Universitaire de Cardiologie et de Pneumologie de Québec, 2725 Chemin Sainte-Foy, Québec City, Québec G1V 4G5, Canada. E-mail: francois.lellouche{at}criucpq.ulaval.ca
See the Related Editorial on Page 1627
Dr Lellouche is co-inventor of the FreeO2 system and co-founder of Oxynov, a company that develops automated respiratory support systems; no support was received from this company for the study. The other authors have disclosed no conflicts of interest.
- Copyright © 2020 by Daedalus Enterprises